-
The Food and Drug Administration approved 35 brand new medicines in its fiscal year 2012, which ended in September, according to an FDA report to be released later today.
FORBES: New Drug Approval Rate At Near-Record High, FDA Says
-
Such pay-for-delay deals arise when generic companies file a challenge at the Food and Drug Administration to the patents that give brand-name drugs a 20-year monopoly.
NPR: Court: Can Drug Companies Pay To Delay Generics?
-
Excessive administration neither serves the spirit of the brand nor the needs of customers.
FORBES: What Snuffs Out The Brand Torch's Flame?
-
By appearing carelessly to brand Republicans as isolationists, and by fuelling partisanship in foreign policy, the administration makes the task much harder.
ECONOMIST: America��s new i-word
-
The fashion brand recently bought a cashmere mill in the Scottish Borders after its owner went into administration.
BBC: Linlithgow Palace hosts Chanel fashion show
-
In a blow to an effort to develop a brand new type of diabetes pill, a panel of advisers to the Food and Drug Administration voted 6 to 9 that the FDA should not approve dapagliflozin, a new type of diabetes drug.
FORBES: Another Blow For Diabetes Pills
-
The Obama administration wants Big Pharma to stop paying generic drug competitors to delay releasing cheaper versions of brand-name drugs.
NPR: 10 Things To Know For Today
-
This morning, the Food and Drug Administration unveiled a series of often graphic images that will be plastered on cigarette packages, above the brand and the outside of the box.
FORBES: Nicotine Addiction And The Birth Of Modern Medicine
-
Yesterday the Food and Drug Administration told doctors to stop prescribing the top 80-milligram dose of simvastatin, also known by the brand name Zocor, to new patients because of a heightened risk of muscle pain.
FORBES: The Scary Thing About the FDA's Simvastatin Decision